8.26 USD
↘ 0.00 (0.06%)PRE MARKET (AS OF 04:12 AM EDT)
Arvinas, Inc
ARVNNASDAQ • USD
Market: OPEN
Shares of Arvinas, Inc (ARVN) are trading at $8.26. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". This is driven by a concerning Altman Z-Score in the distress zone and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest ARVN is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Sep 15, 2026.
Open?$8.26
High?$8.26
Low?$8.26
Prev. Close?$8.26
Volume?4
Avg. Volume?903.0K
VWAP?$8.26
Rel. Volume?0.00x
Bid / Ask
Bid?$7.11 × 100
Ask?$9.34 × 100
Spread?$2.23
Midpoint?$8.23
Valuation & Ratios
Market Cap?540.1M
Shares Out?64.5M
Float?54.6M
Float %?84.7%
P/E Ratio?58.07
P/B Ratio?0.96
EPS?$0.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
Themes
Employees
246
Market Cap
549.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2018-09-27
Address
395 WINCHESTER AVE
NEW HAVEN, CT 06511
Phone: 203-535-1456
NEW HAVEN, CT 06511
Phone: 203-535-1456
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?13
Momentum?85
Short Sent.?24
Piotroski F-Score?6/9Mixed
Altman Z-Score?1.15Distress
Confidence?55%Low
Short InterestHigh
Short % of Float?8.62%Elevated
Short Interest?4.7M
Days to Cover?8.0
Free Float54.6M
Avg Daily Volume585.8K
Settlement Date2026-08-31
Financial Health
Current Ratio?7.91Strong
Quick Ratio?7.91Strong
Cash Ratio?1.14Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score87/100
P/E?58.1PRICEY▾
Peers100
S&P9
P/B?0.96CHEAP▾
Peers100
S&P97
P/S?1.71CHEAP▾
Peers100
S&P74
P/FCF?N/A▾
EV/EBITDA?-40.9CHEAP▾
S&P97
EV/Sales?1.41CHEAP▾
Peers100
S&P85
Returns & Efficiency
ROE?1.7%WEAK▾
Peers50
S&P17
ROA?1.4%WEAK▾
Peers50
S&P15
Cash Flow & Enterprise
FCF?$-208800000
Enterprise Value?$446.1M
Fundamentals ratios updated end of day